ApprovalTrail

Drug · DIN 01919598

PARNATE

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since July 16, 2002; first marketed December 31, 1992.
Drug Identification Number (DIN)
01919598
Company (DIN owner)
Glaxosmithkline IncMississauga, Ontario, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Tranylcypromine N06AF04
Class
Human
Record last updated
October 5, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
TRANYLCYPROMINE (TRANYLCYPROMINE SULFATE)10 MG

Notices of Compliance

Health Canada approvals that name this DIN.